Dyslexia Treatment Market Report 2026: $40+ Bn Opportunities, Trends, Competitive Landscape, Strategies, And Forecasts, 2020-2025, 2025-2030F, 2035F

(MENAFN- GlobeNewsWire - Nasdaq) The dyslexia treatment market is poised for growth driven by digital education platforms, personalized learning, and early intervention. Opportunities lie in expanding structured literacy programs, multisensory approaches, and assistive tools, with significant potential in Asia-Pacific and amid rising neurological disorders.

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Dyslexia Treatment Market Report 2026" has been added to ResearchAndMarkets's offering.

The dyslexia treatment market is poised for significant growth, expanding from $30.17 billion in 2025 to $32.27 billion in 2026, with a CAGR of 6.9%. The historic growth is fueled by increased awareness of learning disabilities, special education programs, and the integration of school-based interventions and literacy curricula, alongside therapist accessibility.

Forecasts indicate a further rise to $40.92 billion by 2030, at a CAGR of 6.1%. Key drivers include the rise in digital education platforms, personalized learning, and early screening initiatives. Emerging trends involve the adoption of structured literacy programs, multisensory learning, and the utilization of digital tools for assistive learning.

Significant growth in the dysautonomia market complements these developments, driven by the increase in chronic diseases, which currently affects a significant portion of the global population. Dysautonomia's impact on essential bodily functions exacerbates symptoms of chronic conditions, highlighting the need for targeted medical interventions.

Additionally, the prevalence of neurological disorders, influenced by demographic shifts and improved diagnostics, contributes to the growing demand for dyslexia treatments. Multisensory learning approaches enhance cognitive processing, aiding individuals with neurological learning challenges.

Companies like Promova Limited have introduced advanced solutions, such as Dyslexia Mode 2.0, featuring enhancements like adjustable fonts and supportive auditory elements, promoting a more inclusive learning environment. This highlights a significant trend of developing technology-driven solutions catering to the needs of neurodivergent learners.

Key players include Pfizer Inc., Astrazeneca Plc, Novartis AG, and Speechify Inc., among others. While North America holds a major share of the market, Asia-Pacific is anticipated to witness the fastest growth. These regions are strategically positioned in the comprehensive market report, covering vast geographical data, including countries like the USA, UK, China, and India.

While tariffs pose challenges by impacting the cost of imported educational resources, they also encourage the proliferation of locally developed learning tools. These adaptive solutions offer cost-effective intervention models tailored to specific regional needs.

The dyslexia treatment market research report provides detailed insights and statistics, capturing a holistic view of the market scenario. It covers market segments, trends, opportunities, and competitor analysis, equipping industry stakeholders with the necessary data to navigate and thrive in this evolving sector.

The market value includes revenues from services like literacy programs and assistive technologies, and sales of related goods. The report distinguishes between factory gate values and consumption values, ensuring a comprehensive understanding of economic flows within the sector.

Key Attributes:

Report Attribute	Details
No. of Pages	250
Forecast Period	2026 - 2030
Estimated Market Value (USD) in 2026	$32.27 Billion
Forecasted Market Value (USD) by 2030	$40.92 Billion
Compound Annual Growth Rate	6.1%
Regions Covered	Global

Companies Featured

• Pfizer Inc.
• Astrazeneca Plc
• Novartis AG
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Purdue Pharma
• Apotex Corporation
• Endo International Plc
• Amneal Pharmaceuticals LLC
• Unither Pharmaceuticals LLC
• RPG Life Sciences Ltd.
• Jubilant Pharma Limited
• Breckenridge Pharmaceutical Inc.
• Rhodes Pharmaceuticals L.P.
• Cian Healthcare Pvt. Ltd
• Lexia Learning Systems LLC
• Wallace Pharmaceuticals Ltd.
• Ironshore Pharmaceuticals Inc.
• DK Pharmachem Pvt Ltd.
• Speechify Inc.
• Lingit AS
• Lyfta
• Nessy Learning Ltd.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Dyslexia Treatment Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN14042026004107003653ID1110981509